Bromocriptine in pregnancy: Safety aspects-Reference-Cited by-同舟云学术

Bromocriptine in pregnancy: Safety aspects

Published:1987-09 Issue:17 Volume:65 Page:823-827
ISSN:0023-2173
Container-title:Klinische Wochenschrift
language:en
Short-container-title:Klin Wochenschr

Author:

Krupp P.,Monka C.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01727477.pdf

Reference15 articles.

1. Anonymous National Foundation/March of Dimes (1975) Facts. National Foundation, New York

2. del Pozo E, Krupp P (1984) Endocrine effects of dopamine receptor stimulation on the fetal-maternal unit. Drugs and Pregnancy. Academic Press, London, pp 191–201

3. Deutsche Forschungsgemeinschaft (German Research Council) (1977) Schwangerschaftsverlauf und Kindsentwicklung. Harald Boldt, Boppard, S 86

4. Franks S, Jacobs HS, Hull MG (1977) Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol 84:241

5. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton, Ill

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinical, Pathological, and Prognostic Features in <i>BRCA</i> Mutant and Wild-Type Male Breast Cancer Patients;European Journal of Breast Health;2022-10-01

2. Hyperprolactinemia and Preconception Management;Pituitary Disorders throughout the Life Cycle;2022

3. The patient with hyperprolactinemia;Assisted Reproduction Techniques;2021-06-04

4. Conservative management of gestational gigantomastia: A case report;Journal of Gynecological Research and Obstetrics;2021-05-10

5. Outcomes of Patients with Macroprolactinoma Desiring Pregnancy: Follow-Up to 23 Years from a Single Center;Hormone and Metabolic Research;2021-04-26